Klimko Artsiom, Andronic Octavian, Lu Victor Yan Zhe, Dimitriou Dimitris, Hoch Armando, Zingg Patrick O
Balgrist University Hospital, University of Zurich, Zurich, Switzerland.
Department of Orthopaedics and Traumatology, Chinese University of Hong Kong, Sha Tin, Hong Kong, China.
J Arthroplasty. 2025 Jul 3. doi: 10.1016/j.arth.2025.06.034.
Femoral impaction bone grafting (IBG) is widely used in revision total hip arthroplasty for cases with severe bone loss. The purpose of this systematic review and meta-analysis was to assess survivorship and patient-reported outcome measures (PROMs) following femoral IBG.
The systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies reporting on femoral IBG in revision total hip arthroplasty with a minimum follow-up of 12 months were included. A random-effects model and the inverse-variance weighting method were used for meta-analysis. Heterogeneity was assessed using Higgins and Thompson's I statistic and Cochran's Q test.
The systematic search included a total of 45 studies, comprising 4,102 hips in 3,805 patients. The overall 10-year survivorship for femoral IBG was 95% (confidence interval 92 to 97), with significant data heterogeneity (I = 79%, P < 0.01). Patients who had higher Endo-Klinik (EK) grades of femoral bone loss (III and IV) had significantly lower 10-year survival rates (90.9 versus 97.4% for EK grades I and II, P = 0.048). Neither patient age (≥ 65 years: 94.5 versus < 65 years: 96.6%, P = 0.23) nor stem length (short stems: 95.5 versus long stems: 94.8%, P = 0.86) significantly affected 10-year survival outcomes. PROMs included the Harris Hip Score, which notably improved postsurgery (standardized mean difference: 10.7, 95% confidence interval: 8.26 to 13.05, I = 99%).
Hip revision arthroplasty with femoral IBG demonstrates high long-term (10-year) survivorship rates (95%, 92 to 97%, I = 79%) and significant improvements in PROMs, specifically the Harris Hip Score (I = 92%), especially in cases with moderate bone loss (EK stages I and II). There was a lower survivorship (90%) in hips with severe bone defects (EK stages III and IV), regardless of additional fixation.
股骨打压植骨术(IBG)广泛应用于严重骨量丢失的翻修全髋关节置换术。本系统评价和荟萃分析的目的是评估股骨IBG术后的生存率和患者报告结局指标(PROMs)。
本系统评价遵循系统评价和荟萃分析的首选报告项目指南。纳入报告翻修全髋关节置换术中股骨IBG且随访至少12个月的研究。采用随机效应模型和逆方差加权法进行荟萃分析。使用Higgins和Thompson的I统计量以及Cochran's Q检验评估异质性。
系统检索共纳入45项研究,包括3805例患者的4102髋。股骨IBG的总体10年生存率为95%(置信区间92%至97%),存在显著的数据异质性(I = 79%,P < 0.01)。股骨骨量丢失Endo-Klinik(EK)分级较高(III级和IV级)的患者10年生存率显著较低(EK I级和II级分别为90.9%和97.4%,P = 0.048)。患者年龄(≥65岁:94.5% vs <65岁:96.6%,P = 0.23)和柄长度(短柄:95.5% vs长柄:94.8%,P = 0.86)均未显著影响10年生存结局。PROMs包括Harris髋关节评分,术后显著改善(标准化均数差值:10.7,95%置信区间:8.26至13.05,I = 99%)。
股骨IBG的髋关节翻修置换术显示出较高的长期(10年)生存率(95%,92%至97%,I = 79%),PROMs有显著改善,特别是Harris髋关节评分(I = 92%),尤其是在中度骨量丢失(EK I期和II期)的病例中。严重骨缺损(EK III期和IV期)的髋关节生存率较低(90%),无论是否有额外固定。